[Clinical experiences with vinblastine sulfate].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000505:Alopecia / Q000139:chemically induced; D001853:Bone Marrow / Q000187:drug effects*; D001854:Bone Marrow Cells; D002875:Chromosomes / Q000187:drug effects*; D003864:Depression, Chemical; D004920:Erythropoiesis / Q000187:drug effects; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy*; D006801:Humans; D007951:Leukemia, Myeloid / Q000188:drug therapy*; D007970:Leukopenia / Q000139:chemically induced; D008297:Male; D008875:Middle Aged; D008938:Mitosis / Q000187:drug effects; D010523:Peripheral Nervous System Diseases / Q000139:chemically induced; D013431:Sulfates / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use*; D014747:Vinblastine / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use*
D013431:Sulfates; D014747:Vinblastine
Klinische Erfahrungen mit Vinblastinsulfat.